Purpose. Multidrug-resistant Klebsiella pneumoniae strains are regularly involved in hospital outbreaks. This study describes an ESBL-producing K. pneumoniae clone (ST607-K25) responsible for a nosocomial outbreak in a neonatal intensive care unit.
INTRODUCTION
Klebsiella pneumoniae (Kp) was described for the first time by Carl Friedl€ ander in 1882 as the agent responsible for pneumonia [1] . Kp is found in the environment and can colonize human and animal mucosal tissue, but it can also behave like a community and nosocomial opportunistic pathogen. Kp mainly infects chronic alcoholics, diabetics, newborns and acute or chronic immunocompromised patients, as well as patients hospitalized in intensive care units. Klebsiella spp. are a common causative agent for respiratory diseases such as pneumonia, especially in patients with chronic airway obstruction or ventilator-associated pneumonia, but are also involved in urinary tract and bloodstream infections. These infections can develop into dangerous systemic diseases [2] [3] [4] [5] [6] .
Klebsiella spp. are responsible for 8 % of all nosocomial infections in Europe, mainly K. pneumoniae, which is more often involved compared to K. oxytoca. Multidrug-resistant (MDR) strains, notably extended-spectrum beta-lactamase (ESBL)-producing strains, are regularly involved in nosocomial outbreaks [2] . These strains are able to acquire additional resistance mechanisms and virulence factors in particular via plasmids, which accounts for their well-developed capacity to disseminate across healthcare units and their invasive power in the human body. MDR Kp infections are reported increasingly frequently and have become a serious public health concern in Europe. According to the European Antimicrobial Resistance Surveillance Network (EARS-net) results for Europe for 2016, 4015 of 27 420 Kp isolates (14.6 %) responsible for invasive infections (blood or cerebrospinal fluid) expressed combined resistance to third-generation cephalosporins, fluoroquinolones and aminoglycosides.
Considering the high prevalence of Kp infections, and the ability of this species to acquire multiple drug resistance and virulence factors, this Gram-negative rod is part of the ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa and Enterobacter sp.) [7] .
In this study, we report an outbreak of ESBL-producing Kp (ESBL-Kp) strains collected between July and September 2013 in Amiens (France), from the university hospital's neonatal intensive care unit. Genotyping was first investigated by enterobacterial repetitive intergenic consensuspolymerase chain reaction (ERIC-PCR) and repetitive extragenic palindromic-PCR (REP-PCR), then confirmed by the MLST method. Genetic characterization of the mechanisms of resistance to beta-lactam antibiotics, aminoglycosides and fluoroquinolones, as well as virulence factors, was investigated. To the best of our knowledge, these results describe for the first time a hypothetical new epidemic clone ST607 responsible for a rapid nosocomial outbreak.
METHODS
Bacterial isolates, patients and clinical and epidemiological features Between July and September 2013, 14 strains (numbered [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] were collected from 13 newborns aged 5-55 days and hospitalized in Amiens university hospital's neonatal intensive unit (Table 1) . Six strains were isolated from clinical samples and eight strains were isolated from rectal swabs. Rectal swabbing is part of routine clinical care. Strains 4 and 6 were collected from the same patient. A descriptive study based on electronic records was conducted to describe demographic data and clinical events related to ESBL-Kp colonizations or infections. Following culture on agar plates, bacterial species identification was performed by MALDIToF mass spectrometry (MALDI Biotyper; Bruker Daltonics, France). Strains were stored at À80 C in cryovials.
Antibiotic susceptibility testing was performed on MuellerHinton agar plates with the disk diffusion method (Biorad, Marne-la-Coquette, France) according to CA-SFM/ EUCAST guidelines [8] . Phenotypic ESBL detection was performed according to the combined antibiotic disks method (between third-generation cephalosporins and clavulanic acid) and observing cefoxitin susceptibility. The ESBL-producing strain K. quasipneumoniae subsp. similipneumoniae ATCC 700603 was tested as control for antibiotype determination [9, 10] .
In order to highlight the gene(s) encoding for beta-lactamase production (bla), multiplex-PCR screening was performed according to the procedure described by Dallenne et al. [11] . This method consists of two assays with two different primer sets for the detection of genes encoding the following enzymes: TEM, OXA and SHV (assay I); and CTX-M groups 1, 2 and 9 (assay II). Strain ATCC 700603 was used as positive control for bla SHV-18 [9, 10] , and strain 17 was used as positive control for bla SHV-1 , bla TEM-1 , bla OXA-1 and bla CTX-M-15 . Sequencing of bla SHV , bla TEM and bla CTX-M-group-1 was then performed with different primers to identify allelic variants (Table 2 ) [12] [13] [14] . Consensus sequences were analysed online using BIGSdb-Kp and Lahey's Database [15] [16] [17] .
Quinolone resistance-determining regions (QRDR) of DNA gyrase and type IV topoisomerase were amplified and then sequenced using the primers previously designed for gyrA [18] , gyrB [19] , parC [20] and parE [21] . Primers used for sequencing are listed in Table 2 , with published references. Multiplex-PCR was then performed to screen eight plasmid-mediated quinolone resistance determinants (PMQR): qnrABCDS (DNA gyrase protection proteins), qepA and oqxAB (efflux pumps) and aac(6¢)-Ib-cr (variant of a common aminoglycoside-modifying enzyme) [22] . CTX-M-I gp R seq CAGCGCTTTTGCCGTCTAAG gyrA6 CGACCTTGCGAGAGAAAT gyrA QRDR [18] gyrA631R GTTCCATCAGCCCTTCAA gyrB_F CTCCTCCCAGACCAAAGACA gyrB QRDR [19] gyrB_R TCACGACCGATACCACAGCC parC-F-2 ATGTACGTSATCATGGAC parC QRDR [20] parC-R-2 AGGATGTTCGGCAGACG parE Fo853 GACCGAAAGCTACGTCAACC parE QRDR [21] parE Re1810 GTTCGGATCAAGCGTGGTTT parE Foseq1126 GCCCAGCGCCGTATGCGTGC 
Molecular typing methods
ERIC-PCR and REP-PCR genomic fingerprinting methods were performed using ERIC2, REP1R-I and REP2-I primers [23] . Multi-locus sequence typing was performed according to protocol 2 described by the Pasteur Institute website [16, 24] . FASTA sequences were compared with BIGSdb-Kp [15] .
Detection of virulence factors and capsular serotypes
Genes encoding capsular serotypes K1 or K2 and specific virulence factors involved in iron acquisition systems (entB, ybtS, iutA, kfu), allantoin metabolism (all), hyper-mucoviscous phenotype (rmpA) and biofilm formation (mrkD) were researched using a multiplex-PCR assay following Compain et al [25] . Two clinical strains were selected from our collection for their hyper-mucoviscous phenotype and invasive behaviour, and were used as controls: strains 15 (ST23-K1) and 16 (ST3240-K2). We also performed wzi sequencing, as described by Brisse et al., for capsular typing of ST607 strains [26] . Allele and K-type were determined using the BIGSdb genome database.
RESULTS

Clinical and epidemiological features
The epidemic period extended from 22 July to 3 September 2013. Sixteen patients were positive for ESBL-Kp colonization and/or infection but after a previous screening study only 13 patients were positive for the ST607 clone. Any ESBL-Kp strain present was detected two months before and after this period (Fig. 1) . The incidence rate of ST607 Kp colonization and/or infection (per 100 admissions) during the epidemic period was 9.46 (5.27-15.36). The incidence density of ST607 Kp colonization and/or infection (per 1000 patient-days) during the epidemic period was 15.3 (8.4-25.5).
All patients were hospitalized on the same floor and supported by the same staff. These premature newborns received probabilistic antibiotic therapy with a combination of cefotaxim and gentamicin. These neonates born in the context of pathological pregnancy were suspected of having neonatal infection. This early therapy may have affected the development of microbiota and exerted selective pressure on the intestinal flora. At least 8 of 13 patients involved in the outbreak were diagnosed with one or several ST607-Kprelated infections. Infected sites included respiratory tract (n=8), urinary tract (n=5), blood (n=3) and eyes (n=2). Three infected patients were also positive for intestinal colonization. No deaths were reported. The data are shown in Table 1 .
Antimicrobial resistance characterization
Fourteen clinical strains were collected in the neonatal intensive care unit between July and September 2013 ( Table 1 ). All strains exhibited an ESBL phenotype and were therefore resistant to all third-generation cephalosporins and fully susceptible to cefoxitin and carbapenems. All strains were resistant to gentamicin, tobramycin and netilmicin, but amikacin remained effective. Only strain 4 was susceptible to all quinolones, including nalidixic acid. These results suggest PMQR and aminoglycoside-modifying enzyme (AME) carriage, and potential QRDR mutations.
Detection of beta-lactamase(s) gene(s) was initially performed. Three specific fragments for bla SHV , bla TEM and bla CTX-M-group-I were identified Fig. 2 . Sequencing of bla genes revealed variants SHV-1, TEM-1 and CTX-M-15. QRDR sequencing for gyrA/gyrB and parC/parE genes did not reveal any mutations in these regions known to confer chromosomal quinolone resistance. In order to explain phenotypic quinolone resistance, multiplex-PCR for detection of eight PMQR determinants was performed. Two specific fragments for aac(6¢)-Ib-cr (14/14 strains) and qnrB (13/14 strains) were detected (Fig. 3) . Interestingly, two strains isolated from the same newborn (strains 4 and 6) showed 
Detection of virulence factors and capsular serotypes
In view of the rapid spread of this MDR clone, we investigated the virulence factors carried by these strains. Multiplex-PCR was performed, including the detection of seven virulence factors and K1/K2 capsular serotypes ( Fig. 5 and Table 3 ). All ST607 strains (n=14/14) carried genes entB and mrkD and some (n=12/14) carried the additional gene ybtS. Single reactions confirmed these results. A non-specific fragment (~1050 bp) was also detected. TA-cloning, followed by sequencing and submission to the BLAST database, showed 99 % homology (605/607 nucleotides) with type 1 fimbrial protein from K. pneumoniae strain AR_0046 (accession number CP032222.1). Multiplex-PCR for strains 15 (ST23-K1) and 16 (ST3240-K2) demonstrated the sensitivity of the assay and the specificity of K1 and K2 amplification.
Despite negative string tests and amplification of genes encoding for K1 and K2 capsular serotypes, capsular production was detected on microscopic examination after Gram and India ink staining. Sequencing identified allele wzi-133 corresponding to the K25 serotype.
DISCUSSION
The Kp ST607 profile has been referenced since 2011 on BIGSdb-Kp, with only one Chinese isolate added in 2016. In the present study, we describe 14 MDR ST607 isolates. Except for strain 4, which was susceptible to nalidixic acid and fluoroquinolones, all strains expressed the same phenotypic and genotypic resistance patterns. We identified two genes encoding for narrow-spectrum beta-lactamases (bla SHV-1 and bla TEM-1 ) and one gene encoding for an ESBL (bla CTX-M-15 ), the most prevalent ESBL gene worldwide [27, 28] . bla SHV-1 is chromosomally located in K. pneumoniae and is probably responsible for the plasmid-mediated diffusion of SHV-like enzymes [29, 30] . A previous study in Italy demonstrated the existence of Kp strains co-harbouring genes bla TEM-1 and bla CTX-M-15 [31] . Several studies have demonstrated that aac(6')-Ib-cr enzymes are strongly associated with ESBL in Enterobacteriaceae isolates, such as bla CTX-M-15 -producing Escherichia coli and K. pneumoniae strains [31] [32] [33] . Furthermore, this type of Kp strain is particularly prevalent in paediatric units, as reported in the present study [34] . These resistance patterns may have resulted from horizontal transfer by conjugative plasmids, as reported in Korean and Spanish studies [35, 36] . More precisely, one Korean study indicated horizontal transfer of this aminoglycoside acetyltransferase between different species, including Kp, and suggested a strong correlation between aac(6')-Ib-cr, bla TEM-1 and bla CTX-M-group-I (like bla CTX-M-15 ) [36] .
The oqxAB pump is encoded by genes oqxA and oqxB and belongs to the resistance-nodulation-division (RND) family. Substrates of this multidrug-resistant pump include nalidixic acid, flumequine, norfloxacin, ciprofloxacin, trimethoprim and chloramphenicol [37] [38] [39] . This pump is widely distributed in wild-type Kp strains as it is located on the chromosome, but usually does not confer phenotypic resistance to quinolones. The oqxAB genes could be hosted on a pOLA52 plasmid, in a composite transposon flanked by IS26. pOLA52 allowed horizontal spread to other Enterobacteriaceae, mainly MDR strains. Moreover, the loss of oqxR repressor function during transposition events could explain overexpression of the pump function when oqxAB genes are plasmid-located [40] [41] [42] [43] [44] [45] [46] . In the present study, multiplex-PCR provided weak and inconsistent amplification for oqxAB (e.g. strains 8 and 9, Fig. 3 ) [22] , but monoplex-PCR confirmed the presence of these genes in the 14 ST607 strains. However, further investigations are necessary to determine the chromosomal or plasmid localization of oqxAB genes.
Several Kp clones, such as ST23, are described as hypervirulent (hvKP) and regularly show a hyper-mucoviscous phenotype on agar plates [47] . These hyper-mucoviscous strains are linked to production of several specific capsular serotypes (mainly K1 and K2) and the 'regulator of mucoid phenotype A' (rmpA/rmpA2) complex. Moreover, various elements may render the strain more virulent, such as biofilm formation (with fimbriae), additional iron acquisition systems (siderophores) or allantoin metabolism [47, 48] . The majority of the ST607 strains involved in this outbreak carried at least two siderophores: enterobactin, a catecholate-siderophore, and yersiniabactin, a phenolate siderophore. Siderophores may play different roles in colonization, inflammation and dissemination. Enterobactin is 'classic' and widely spread among Kp isolates, while yersiniabactin-encoding genes are localized on a mobilizable high-pathogenicity island distributed among different Enterobacteriaceae species [25, 49] . In the case of Kp, the ybt-locus is usually localized on a self-transmissible 'integrative and conjugative element' named ICEKp [50, 51] . Nevertheless, a plasmid-encoded form of the ybt-locus was identified in 2018 by Lam et al. [51] . Additional siderophores such as yersiniabactin are generally considered to be part of the virulence factors that characterize hvKP strains. Otherwise, ICEKp is known for sometimes carrying other virulence factors such as salmochelin or colibactin [47-49, 52, 53] .
Lipocalin 2 (Lcn2) is an innate immune protein secreted by mucosal surfaces and neutrophils. Lcn2 has a bacteriostatic effect induced by enterobactin binding and competition with enterobactin receptors, and also by the pro-inflammatory effect [52, 54] . Because yersiniabactin escapes Lcn2 inhibition, its concomitant production with the ubiquitous enterobactin results in increased bacterial loads in the lungs and in nasal and oral secretions. Yersiniabactin production by Kp is therefore a risk factor for bronchopneumonia and promotes inter-human spread via secretions [52, 55] . However, in pneumonia, acute inflammation leads to leakage of blood exudate into the perivascular space and results in the inhibiton of yersiniabactin by the iron carrier transferrin. These elements highlight why yersinibactin-producing isolates are over-represented among respiratory tract samples but rare in blood and urine [52, 56] . Yersiniabactin production represents a high-cost for the bacterial cell, and ybtlocus could be lost when Kp does not require yersiniabactin to grow in a specific niche or environment [51] . Based on these comments, we presume that the absence of the ybtS gene in strains 3 and 6, respectively isolated from blood and urine, could be explained by Kp fitness which is dependent on the colonization site.
Multiplex-PCR also allowed the detection of mrkD, a gene encoding a subunit of type 3 fimbriae, in our ST607 clone. Fimbriae are adhesive structures on the surface of Kp involved in biofilm formation. In particular, type 1 (encoded by the fim operon) and type 3 fimbriae (encoded by the mrk operon) are considered to be virulence factors expressed by almost all Kp strains [57] .
ST607 strains were negative for capsular serotype K1 and K2 amplification, and molecular typing by wzi sequencing revealed a K25 capsular serotype. Two previous studies described dissemination of serotype K25 and SHV-4 (ESBL)-producing strains isolated in 14 French hospitals (mainly Paris), between 1987 and 1988 [58, 59] .
During this study, we were particularly interested in two particular strains (strains 4 and 6) isolated from the same 
newborn. First, strain 4, rapidly isolated from a rectal swab, was susceptible to quinolones unlike strain 6, isolated from a urine sample three days later. Second, strain 4 lacked qnrB protein in contrast to strain 6, which may explain their varied susceptibility to quinolones.
To the best of our knowledge, this study describes, for the first time, a multidrug-resistant ST607 K. pneumoniae strain responsible for a rapid nosocomial outbreak in a neonatal intensive care unit. Robust management of the outbreak by the medical and paramedical staff, in collaboration with microbiologists and the nosocomial infection department, allowed a successful interruption of the spread of this clone. The measures employed to control the outbreak were: weekly screening of neonates; cohorting of neonates with dedicated nursing staff and materials; and reminders about hand-washing, jewellery wearing and cleaning of surfaces. Premature newborns hospitalized in intensive care units are vulnerable and immunocompromised patients. Moreover, intense nursing is an additional risk factor for nosocomial infections. The detection of a gene (ybtS) belonging to the ybt-locus could partly explain its pathogenicity and high diffusion potential, despite its non-hyper-mucoviscous phenotype, classic capsular serotype and the absence of aerobactin siderophore or allantoin metabolism. Additional investigations may eventually reveal the presence of virulence factors more rarely associated with ICEKp, such as salmochelin (a modified enterobactin that evades Lcn2 inhibiton) or the genotoxic polyketide named, colibactin. Despite the weak phenotypic resistance individually conferred by these elements, PMQR determinants are also worrying elements because their accumulation can lead to higher resistance levels and promote the selection of mutant strains [60, 61] . Treatment by fluoroquinolones as an alternative to b-lactams could therefore be compromised.
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